The Living Guidelines: UA/NSTEMI Recommendations for UA/NSTEMI in Diabetic Patients Suggest Revisions to the CLASS IIa Guidelines

Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see the disclaimers page for important information regarding limitations of the information found here. In suggesting edits to the guidelines, WikiDoc suggests that the following classification scheme be used. Read more about the classification scheme used by the ACC / AHA Guidelines Committee here.

Instructions on How to Edit the Guidelines:
 * Log in
 * Click on "Edit"
 * Type in changes to guidelines
 * Click "Save page" at the bottom of the page

Class IIa Guidelines

 * 1) For patients with UA / NSTEMI and multi vessel disease, CABG with use of the internal mammary arteries can be beneficial over PCI in patients being treated for diabetes mellitus. (Level of Evidence: B)
 * 2) Percutaneous coronary intervention is reasonable for UA / NSTEMI patients with diabetes mellitus with single-vessel disease and inducible ischemia. (Level of Evidence: B)
 * 3) In patients with UA / NSTEMI and diabetes mellitus, it is reasonable to administer aggressive insulin therapy to achieve a glucose <150 mg/dL during the first 3 hospital (intensive care unit) days and between 80 and 110 mg/dL thereafter whenever possible. (Level of Evidence: B)